Analysts at Bank of America (BAC) downgraded their rating on the shares of Bio-Reference Laboratories Inc. (BRLI) to ‘Underperform’ from ‘Buy’ in a research report issued to clients and investors on Thursday. The target price has been lowered to $32.00/share. Bio-Reference Laboratories shares closed at $32.60 yesterday. The firm’s target price suggests a potential upside of 1.28% from the company’s current price of $29.70.
Analysts at Raymond James downgraded their rating on the shares of Visa Inc. (V) to ‘Market Perform’ from ‘Outperform’. Visa Inc.’s shares closed at $217.13 yesterday. The firm’s target price suggests a potential upside of about 8% from the company’s current price of $215.20. Currently Visa boasts nine “Strong Buys” endorsements, compared to 17 “Buys” and 5 “Holds”. No analysts rate it a ‘Sell.’ Visa has a median Wall Street price-per-share target of $250 with a high target of $281.00.
Analysts at Wedbush initiated coverage on Whole Foods Market, Inc. (WFM) with a ‘Neutral’ rating and a $40.00 price target in a research report issued to clients on Thursday. Whole Foods shares closed at $39.80 yesterday. The firm’s target price suggests a potential upside of 2.43% from the company’s current price of $39.07.
GT Advanced Technologies Inc. (GTAT) was downgraded by Raymond James analysts to ‘Underperform’ from ‘Market Perform’ rating Thursday. GT Advanced Technologies shares, which previously closed at $18.57, were down 3.61% at $17.85 in midday trade, moving within a 52-week range of $6.28 to $20.54.
Analysts at DA Davidson downgraded their rating on the shares of Lululemon (LULU) ahead of earnings to ‘Neutral’. The target price has been lowered to $44.00 from $46.00. The firm believes ticker’s new price-per-share appropriately reflects the balance of long-term growth potential and near-term execution risks. DA Davidson’s new PT suggests a potential downside of about 9% from the company’s current price of $40.42.
Leave a Reply